AR027161A1 - Metodo para inducir la proliferacion neovascular y regeneracion tisular - Google Patents
Metodo para inducir la proliferacion neovascular y regeneracion tisularInfo
- Publication number
- AR027161A1 AR027161A1 ARP010102313A ARP010102313A AR027161A1 AR 027161 A1 AR027161 A1 AR 027161A1 AR P010102313 A ARP010102313 A AR P010102313A AR P010102313 A ARP010102313 A AR P010102313A AR 027161 A1 AR027161 A1 AR 027161A1
- Authority
- AR
- Argentina
- Prior art keywords
- tissular
- inducting
- regeneration
- neovascular proliferation
- neovascular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP010102313A AR027161A1 (es) | 2001-05-15 | 2001-05-15 | Metodo para inducir la proliferacion neovascular y regeneracion tisular |
PCT/US2002/014508 WO2002091995A2 (en) | 2001-05-15 | 2002-05-13 | Method to induce neovascular formation and tissue regeneration |
EP10011850A EP2308502A1 (en) | 2001-05-15 | 2002-05-13 | Method to induce neovascular formation and tissue regeneration |
ES02729151.7T ES2566344T3 (es) | 2001-05-15 | 2002-05-13 | VEGF-A para inducir regeneración del tejido miocárdico |
AU2002259162A AU2002259162A1 (en) | 2001-05-15 | 2002-05-13 | Method to induce neovascular formation and tissue regeneration |
CA002447343A CA2447343A1 (en) | 2001-05-15 | 2002-05-13 | Method to induce neovascular formation and tissue regeneration using vegf |
BRPI0209824-5 BRPI0209824B8 (pt) | 2001-05-15 | 2002-05-13 | método ex vivo ou in vitro para induzir cardiomiogênese |
EP02729151.7A EP1441682B1 (en) | 2001-05-15 | 2002-05-13 | Vegf-a to induce myocardial tissue regeneration |
MXPA03010532A MXPA03010532A (es) | 2001-05-15 | 2002-05-13 | Metodo para inducir formacion neovascular y regeneracion. |
US10/714,449 US7563777B2 (en) | 2001-05-15 | 2003-11-17 | Method to induce neovascular formation and tissue regeneration |
US12/487,398 US20090275645A1 (en) | 2001-05-15 | 2009-06-18 | Method to induce neovascular formation and tissue regeneration |
US14/176,616 US20140341972A1 (en) | 2001-05-15 | 2014-02-10 | Method to induce neovascular formation and tissue regeneration |
US15/173,867 US20160346352A1 (en) | 2001-05-15 | 2016-06-06 | Method to induce neovascular formation and tissue regeneration |
US15/490,198 US20170252405A1 (en) | 2001-05-15 | 2017-04-18 | Method to induce neovascular formation and tissue regeneration |
US15/945,982 US20180296641A1 (en) | 2001-05-15 | 2018-04-05 | Method to induce neovascular formation and tissue regeneration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP010102313A AR027161A1 (es) | 2001-05-15 | 2001-05-15 | Metodo para inducir la proliferacion neovascular y regeneracion tisular |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027161A1 true AR027161A1 (es) | 2003-03-19 |
Family
ID=36129783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102313A AR027161A1 (es) | 2001-05-15 | 2001-05-15 | Metodo para inducir la proliferacion neovascular y regeneracion tisular |
Country Status (9)
Country | Link |
---|---|
US (6) | US7563777B2 (es) |
EP (2) | EP1441682B1 (es) |
AR (1) | AR027161A1 (es) |
AU (1) | AU2002259162A1 (es) |
BR (1) | BRPI0209824B8 (es) |
CA (1) | CA2447343A1 (es) |
ES (1) | ES2566344T3 (es) |
MX (1) | MXPA03010532A (es) |
WO (1) | WO2002091995A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2520044T3 (es) | 2007-03-30 | 2014-11-11 | The Cleveland Clinic Foundation | SDF-1 para su uso en el tratamiento de trastornos vasculares periféricos isquémicos |
WO2009079451A2 (en) | 2007-12-14 | 2009-06-25 | The Cleveland Clinic Foundation | Compositions and methods of promoting wound healing |
JP5856059B2 (ja) | 2009-08-28 | 2016-02-09 | ザ クリーブランド クリニック ファウンデーション | 虚血組織を治療するためのsdf−1送達 |
US9663564B2 (en) | 2013-03-15 | 2017-05-30 | The Regents Of The University Of California | Vectors and methods to treat ischemia |
US20140065110A1 (en) * | 2012-08-31 | 2014-03-06 | The Regents Of The University Of California | Genetically modified msc and therapeutic methods |
US10405961B2 (en) | 2013-03-14 | 2019-09-10 | Cell and Molecular Tissue Engineering, LLC | Coated surgical mesh, and corresponding systems and methods |
US10130288B2 (en) | 2013-03-14 | 2018-11-20 | Cell and Molecular Tissue Engineering, LLC | Coated sensors, and corresponding systems and methods |
US20170100029A1 (en) * | 2015-10-13 | 2017-04-13 | The University Of North Carolina At Chapel Hill | Compositions and Methods for Analyzing Collateral Density |
AU2019210204B2 (en) | 2018-01-18 | 2024-05-16 | EndoProtech, Inc. | Treating microvascular dysfunction |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219739A (en) * | 1989-07-27 | 1993-06-15 | Scios Nova Inc. | DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121 |
US6040157A (en) * | 1994-03-08 | 2000-03-21 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
JP2001509168A (ja) * | 1997-01-29 | 2001-07-10 | コーネル リサーチ ファウンデーション、インコーポレイティッド | 血管新生を誘導するためのアデノウイルスベクターの多部位送達 |
US7947472B2 (en) * | 1997-12-24 | 2011-05-24 | Vegenics Limited | Expression vectors and cell lines expressing vascular endothelial growth factor D |
US20010056073A1 (en) * | 1998-07-21 | 2001-12-27 | Ascher Shmulewitz | Gene therapy method for revascularizing ischemic tissue |
US6440945B1 (en) * | 1999-05-27 | 2002-08-27 | Instituto Dermopatico Dell'immacolata | Method of inducing angiogenesis in nonis chemic skeletal muscle |
JP5704780B2 (ja) * | 1999-08-13 | 2015-04-22 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 脈管形成因子の用量および心筋血流を改善するための投与方法 |
-
2001
- 2001-05-15 AR ARP010102313A patent/AR027161A1/es not_active Application Discontinuation
-
2002
- 2002-05-13 MX MXPA03010532A patent/MXPA03010532A/es active IP Right Grant
- 2002-05-13 WO PCT/US2002/014508 patent/WO2002091995A2/en not_active Application Discontinuation
- 2002-05-13 BR BRPI0209824-5 patent/BRPI0209824B8/pt not_active IP Right Cessation
- 2002-05-13 AU AU2002259162A patent/AU2002259162A1/en not_active Abandoned
- 2002-05-13 EP EP02729151.7A patent/EP1441682B1/en not_active Expired - Lifetime
- 2002-05-13 EP EP10011850A patent/EP2308502A1/en not_active Withdrawn
- 2002-05-13 CA CA002447343A patent/CA2447343A1/en not_active Abandoned
- 2002-05-13 ES ES02729151.7T patent/ES2566344T3/es not_active Expired - Lifetime
-
2003
- 2003-11-17 US US10/714,449 patent/US7563777B2/en not_active Expired - Lifetime
-
2009
- 2009-06-18 US US12/487,398 patent/US20090275645A1/en not_active Abandoned
-
2014
- 2014-02-10 US US14/176,616 patent/US20140341972A1/en not_active Abandoned
-
2016
- 2016-06-06 US US15/173,867 patent/US20160346352A1/en not_active Abandoned
-
2017
- 2017-04-18 US US15/490,198 patent/US20170252405A1/en not_active Abandoned
-
2018
- 2018-04-05 US US15/945,982 patent/US20180296641A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR0209824A (pt) | 2004-10-19 |
WO2002091995A8 (en) | 2004-05-06 |
AU2002259162A1 (en) | 2002-11-25 |
ES2566344T3 (es) | 2016-04-12 |
US7563777B2 (en) | 2009-07-21 |
US20170252405A1 (en) | 2017-09-07 |
US20090275645A1 (en) | 2009-11-05 |
EP1441682A1 (en) | 2004-08-04 |
EP2308502A1 (en) | 2011-04-13 |
WO2002091995A2 (en) | 2002-11-21 |
MXPA03010532A (es) | 2005-10-05 |
US20180296641A1 (en) | 2018-10-18 |
US20140341972A1 (en) | 2014-11-20 |
EP1441682B1 (en) | 2016-01-20 |
BRPI0209824B8 (pt) | 2021-05-25 |
CA2447343A1 (en) | 2002-11-21 |
US20160346352A1 (en) | 2016-12-01 |
BRPI0209824B1 (pt) | 2020-11-10 |
EP1441682A4 (en) | 2007-07-11 |
US20050020522A1 (en) | 2005-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60226403D1 (de) | Informationverarbeitungssystem und -verfahren | |
DE60227693D1 (de) | Media inhalt verteilungs -system und -verfahren | |
BR0209704B1 (pt) | método e conjunto para aumento do volume de cabelos. | |
GB0323953D0 (en) | Method and system for secure information | |
AU2003303392A8 (en) | Engine braking methods and apparatus | |
DE60329550D1 (de) | Dokumentklassifikationsverfahren und -anordnung | |
DE60030968D1 (de) | Transfermethode für halbleiterscheiben und haltering | |
ATE373183T1 (de) | Treibriemen und verfahren | |
GB0103130D0 (en) | Media editing method and software thereof | |
DE60207175D1 (de) | System und Verfahren zur Authentifizierung | |
DE60319787D1 (de) | Montageverfahren und -vorrichtung | |
DE60144046D1 (de) | Informationsverarbeitungsystem und Speicherbereich-Zuordnungsverfahren | |
DE602004014707D1 (de) | Informationsverteilungssystem und -verfahren | |
DE60220037D1 (de) | Molekulares speichersystem und verfahren | |
DE602004010534D1 (de) | Verfahren und System zur Bestimmung von Lücken in dem Zellulatelefon-Abdeckungsgebiet | |
DE60143794D1 (de) | Druckverfahren und -Vorrichtung | |
DE60231538D1 (de) | Sputtertarget und herstellungsverfahren dafür | |
BR0207368B1 (pt) | mÉtodo para tratamento e secagem de madeira. | |
AR027161A1 (es) | Metodo para inducir la proliferacion neovascular y regeneracion tisular | |
DE60120945D1 (de) | System und Verfahren zum Bereitstellen von Dienstleistungen | |
DE60232497D1 (de) | Poliervorrichtung und -verfahren | |
NO20054635D0 (no) | Varmebehandlede fischer-tropsch-katalysatorpartikler | |
AU2002318356A8 (en) | Protein modification and maintenance molecules | |
ATE507196T1 (de) | Fischer-tropsch-verfahren | |
DE60231591D1 (de) | Aufzeichnungsvorrichtung und -verfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |